A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)
Public ClinicalTrials.gov record NCT04524403. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia Taking Antipsychotic Medications (GRATITUDE II)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase 2, double-blind, placebo-controlled, randomized study is to assess the safety, efficacy, and pharmacokinetics (PK) of miricorilant (CORT118335) in obese patients with schizophrenia treated with antipsychotic medications.
Study identification
- NCT ID
- NCT04524403
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 9, 2020 (Actual)
- Primary completion
- Jul 29, 2022 (Actual)
- Completion
- Aug 25, 2022 (Actual)
- Last update posted
- Jun 13, 2024
2020 – 2022
United States locations
- U.S. sites
- 40
- U.S. states
- 14
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site #143 | Bentonville | Arkansas | 72712 | — |
| Site # 249 | Little Rock | Arkansas | 72211 | — |
| Site #153 | Culver City | California | 90230 | — |
| Site #239 | Garden Grove | California | 92845 | — |
| Site # 243 | Glendale | California | 91206 | — |
| Site #134 | Lemon Grove | California | 91945 | — |
| Site #163 | Oceanside | California | 92056 | — |
| Site # 247 | Pico Rivera | California | 90660 | — |
| Site # 229 | Rancho Cucamonga | California | 91730 | — |
| Site # 237 | San Diego | California | 92103 | — |
| Site # 150 | Stanford | California | 94305 | — |
| Site #202 | Miami | Florida | 33122 | — |
| Site #144 | Miami Lakes | Florida | 33016 | — |
| Site #144 | North Miami | Florida | 33161 | — |
| Site #241 | Okeechobee | Florida | 34972 | — |
| Site # 240 | Chicago | Illinois | 60640 | — |
| Site #140 | Chicago | Illinois | 60641 | — |
| Site #140 | Lincolnwood | Illinois | 60712 | — |
| Site #225 | Flowood | Mississippi | 39232 | — |
| Site #224 | St Louis | Missouri | 63125 | — |
| Site #217 | Lincoln | Nebraska | 68526 | — |
| Site #151 | Las Vegas | Nevada | 89102 | — |
| Site # 244 | Cedarhurst | New York | 11516 | — |
| Site #216 | New York | New York | 10032 | — |
| Site # 245 | New York | New York | 10036 | — |
| Site #231 | Staten Island | New York | 10312 | — |
| Site #231 | Staten Island | New York | 10314 | — |
| Site # 248 | Charlotte | North Carolina | 28211 | — |
| Site #181 | Raleigh | North Carolina | 27608 | — |
| Site # 181 | Raleigh | North Carolina | 27610 | — |
| Site #107 | Dayton | Ohio | 45417 | — |
| Site # 230 | North Canton | Ohio | 44720 | — |
| Site #166 | Philadelphia | Pennsylvania | 19125 | — |
| Site #235 | Thorndale | Pennsylvania | 19372 | — |
| Site #235 | West Chester | Pennsylvania | 19380 | — |
| Site #223 | Austin | Texas | 78754 | — |
| Site #206 | DeSoto | Texas | 75115 | — |
| Site #066 | Houston | Texas | 77030 | — |
| Site #165 | Richardson | Texas | 75080 | — |
| Site #137 | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04524403, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 13, 2024 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04524403 live on ClinicalTrials.gov.